Urgent Action Needed: Tackling Antimicrobial Resistance at Jeddah Conference

In a recent conference, Tedros Adhanom Ghebreyesus, the Director-General of the World Health Organization (WHO), addressed the urgent issue of antimicrobial resistance (AMR). He stressed that 1.3 million people die each year from superbug infections. He connected the urgency of AMR action to that of climate action.

Dr. Tedros highlighted the need to implement the UN General Assembly’s Political Declaration on AMR, agreed to in September. He outlined three key priorities for low- and middle-income countries:

1. Increase sustainable financing from domestic and international sources.
2. Boost research, development, and innovation to fill the gaps in antimicrobial drug availability.
3. Ensure equitable access to quality antimicrobials while promoting their proper use.

He noted that while inappropriate use of antimicrobials drives AMR, many people die due to a lack of access to these vital medicines. He called for strong collaboration to address AMR effectively.

How does antimicrobial resistance (AMR) affect public health globally?

Interview with Dr. Maria Sanchez, Antimicrobial Resistance Specialist

Editor: Thank you for joining us, Dr. Sanchez. The recent comments by WHO Director-General Dr. Tedros Adhanom Ghebreyesus highlighted the grave global threat of antimicrobial resistance (AMR). What are your thoughts on his emphasis on AMR being as urgent as climate action?

Dr. Sanchez: Thank you for having me. I believe Dr. Tedros makes a vital point. Just as climate change impacts social and economic systems, AMR threatens public health globally. The statistics are alarming—1.3 million deaths annually due to superbugs illustrate that we must treat this issue with the utmost seriousness. The interconnectedness of AMR and climate action speaks to a broader challenge: ensuring our health systems can withstand multiple, overlapping crises.

Editor: Dr. Tedros outlined three critical priorities, especially for low- and middle-income countries. Could you elaborate on why sustainable financing is so important?

Dr. Sanchez: Absolutely. Sustainable financing is essential because without adequate funding, efforts to combat AMR are likely to be fragmented and ineffective. Low- and middle-income countries often struggle with health crises due to limited budgets, which makes it difficult to invest in surveillance systems, research, and access to essential medicines. Mobilizing both domestic and international financing can help fill these gaps and establish a more robust health infrastructure.

Editor: He also highlighted the need for boosted research and equitable access to antimicrobials. How do you see the current landscape in this regard?

Dr. Sanchez: We are in a crisis of innovation when it comes to antimicrobial drugs. Many pharmaceutical companies have deprioritized this area due to low profitability, leaving us with a dwindling pool of effective treatments. Equity in access to these medicines is equally critical; we must ensure that effective treatments are available to those who need them the most, regardless of their geographic or economic barriers. It’s essential that efforts to develop and distribute these medications consider these disparities.

Editor: Saudi Arabia’s Minister of Health emphasized AMR’s impact on public health and global security. In your view, how can countries collectively address this complex issue?

Dr. Sanchez: Collective action is pivotal. Countries must engage in transparent collaborations, sharing knowledge, resources, and best practices. Initiatives like the ‘Jeddah Declaration’ can serve as a framework for this collaboration, emphasizing the need for a global scientific committee and awareness-building measures. Addressing AMR is not merely a health issue—it’s intertwined with economic stability and security, necessitating a unified approach.

Editor: Dr. Hanan Balkhy pointed out that conflict areas exacerbate the AMR problem. What specific challenges do these regions face?

Dr. Sanchez: Conflict areas often suffer from severe disruptions in healthcare infrastructure, which leads to inadequate hygiene, lack of essential medical supplies, and overall deteriorating public health. This creates an environment ripe for the spread of AMR. Addressing these challenges demands targeted interventions that involve all stakeholders, including governments, NGOs, and local communities, to rebuild infrastructure and implement health initiatives tailored to the needs of these populations.

Editor: Lastly, Thanawat Tiensin discussed the role of agriculture in AMR. How significant is antimicrobial use in livestock, and what measures are being considered?

Dr. Sanchez: The overuse of antibiotics in agriculture, particularly in livestock, is a significant contributor to AMR. Measures such as promoting responsible antibiotic use, implementing regulations on agricultural antibiotic sales, and encouraging alternative practices can be effective. It’s essential to harmonize these efforts globally since agricultural practices and their consequences don’t respect national borders. Integrating public health and agricultural sectors will be key to effectively combating AMR.

Editor: Thank you for your insights, Dr. Sanchez. Your expertise sheds a crucial light on this pressing global health issue.

Dr. Sanchez: Thank you for having me; it’s a pleasure to discuss such a significant challenge we face today.

Saudi Arabia’s Minister of Health, Fahad Al-Jalajel, spoke about AMR’s impact on public health, economic stability, and global security. He stressed the need for countries to take new measures against AMR and highlighted the ongoing negotiation of the ‘Jeddah Declaration’, which includes plans for a global scientific committee and a knowledge center to raise awareness.

Dr. Hanan Balkhy, WHO Regional Director, emphasized the importance of addressing AMR across all sectors and involving all stakeholders. She pointed out that tackling AMR is challenging, especially in conflict areas, where lack of hygiene and health resources increases the problem.

Thanawat Tiensin, from the FAO, discussed the organization’s efforts to encourage farmers and producers to reduce antimicrobial use in agriculture. He stated that addressing antibiotic use in livestock is crucial for controlling AMR.

These discussions underscore the urgent need for collective action to combat antimicrobial resistance and preserve the effectiveness of modern medicine for future generations.